Congressional Hearings in 110th U.S. Congress, on pharmaceutical drugs (including trade issues)


U.S. Senate


Appropriations Committee

Subcommittee on Labor, Health and Human Services, and Education 

April 18, 2007 Hearing on Global Health

 

Judiciary Committee

June 6, 2007 Patent Reform: The Future of American Innovation

 

Committee on Health, Education, Labor, and Pensions

March 14, 2007 Drug User Fees: Enhancing Patient Access and Drug Safety

March 8, 2007 Follow-on Biologics

 

Committee on Finance

May 8, 2007 The Medicare Prescription Drug Benefit: Review and Oversight

January 11, 2007 Prescription Drug Pricing and Negotiation: An Overview and Economic Perspectives for the Medicare Prescription Drug Benefit

 


U.S. House of Representatives


Committee on Energy and Commerce

    Subcommittee on Health

June 12, 2007 Legislative Hearing on Discussion Drafts Concerning Prescription Drug User Fee Act Reauthorization, Medical Device User Fee and Modernization Act Reauthorization, Drug Safety, and Certain Pediatric Pharmaceutical and Device Legislation  

May 2, 2007 Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States

    Subcommittee on Commerce, Trade, and Consumer Protection

May 2, 2007 H.R. 1902, Protecting Consumer Access to Generic Drugs Act of 2007

Committee on Foreign Affairs

    Subcommittee on Terrorism, Nonproliferation, and Trade

June 13, 2007 The United States-South Korea FTA: The Foreign Policy Implications

 

Committee on Science and Technology

July 26, 2007 The Globalization of R&D and Innovation, Pt. II: The University Response

June 12, 2007 The Globalization of R&D and Innovation

    Subcommittee on Technology and Innovation

July 17, 2007 The Bayh-Dole Act: The Next 25 Years

 

Committee on Ways and Means

Subcommittee on Health

June 21, 2007 Hearing on Beneficiary Protections in Medicare Part D

June 12, 2007 Hearing on Strategies to Increase Information on Comparative Clinical Effectiveness